Description

IGF-1 LR3 1mg (Long Arg3 Insulin-like Growth Factor-1) is a synthetic modified analogue of human IGF-1, designed for advanced laboratory and scientific research. This variant features an extended half-life and enhanced stability, making it a widely studied compound in experimental models focused on cellular growth signaling and metabolic pathways.

Produced under strict quality standards, IGF-1 LR3 is supplied in a highly purified lyophilized form to ensure consistency and reliability in research applications.

Key Features

• High-Purity Research Grade Peptide
• 1mg Per Vial Concentration for precise experimental use
• Extended Half-Life Variant (LR3 Modification) for research stability
• Sterile Lyophilized Powder Form for improved preservation
• Batch-Tested Quality Assurance with COA availability

Specifications

• Product Name: IGF-1 LR3 (Long R3 IGF-1)
• Strength: 1mg per vial
• Form: Freeze-dried (lyophilized) powder
• Type: Synthetic IGF-1 analogue (modified amino acid sequence)
• Storage: Store in a cool, dry place. Refrigeration recommended after reconstitution in research environments
• Purity: ≥ 99% (subject to batch COA verification)
• Usage: Laboratory and scientific research only

Packaging

Each vial is sealed in sterile, tamper-resistant packaging to ensure product integrity and stability. Every unit includes a unique batch identifier for traceability and quality control.

Quality Control

Each batch may undergo strict analytical testing, including:

• High-Performance Liquid Chromatography (HPLC)
• Mass Spectrometry (if applicable)
• Identity and purity verification
• Certificate of Analysis (COA) support per batch

Important Notice

This product is intended strictly for laboratory and research purposes only. It is not intended for human consumption, medical use, diagnosis, or treatment of any condition.